Shintaro Matsumoto
President & CEO @ Elev X!
Palo Alto, United States
Shintaro Matsumoto is a seed investor at Elev X! in Palo Alto focused on Health Care and Medical. Shintaro Matsumoto is the President and CEO of NEC X.Inc. He previously worked at GRA as a Board Member. Shintaro Matsumoto attended Yokohama National University.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Shintaro Matsumoto invests in
Stages Shintaro Matsumoto invests in
Countries Shintaro Matsumoto invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (30%)
- Medical 2 (20%)
- Legal Tech 2 (20%)
- Medical Device 2 (20%)
- Apps 1 (10%)
Stage
- Seed 6 (60%)
- Pre-Seed 1 (10%)
- Funding Round 1 (10%)
- Venture - Series Unknown 1 (10%)
Country
- United States 5 (50%)
- Canada 1 (10%)
- United Kingdom 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Verdi Expeditions
|
Verdi Expeditions is a scalable platform for agricultural automation and tailored plant health. | $4.7M / Seed / May 15, 2025 | |
SeafoodAI
|
SeafoodAI utilizes advanced technology to improve seafood sourcing, focusing on sustainability and profitability through real-time data insights. The company is pioneering AI-powered solutions, including biometric scanning, to boost seafood sustainability and enhance digital traceability. | $250K / Pre-Seed / Apr 09, 2025 | |
Clikr
|
Clikr is a martech all-in-one platform that revolutionizes fashion and beauty marketing by connecting brands with customers who create impactful content. | Seed / Dec 18, 2024 | |
GPx
|
GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts. | Seed / Nov 12, 2024 | |
Chekable
|
We are on a mission to make intellectual property more accessible. Both patent professionals and inventors need modern AI first tools to make patenting process efficient and intelligent. | Seed / Jul 24, 2024 | |
|
Verdi Expeditions
|
Verdi Expeditions is a scalable platform for agricultural automation and tailored plant health. | May 22, 2024 | |
|
Verdi Expeditions
|
Verdi Expeditions is a scalable platform for agricultural automation and tailored plant health. | Seed / May 22, 2024 | |
Multitude Insights
|
Multitude Insights helps law enforcement agencies leverage their unstructured data. The company was founded in 2021 and is headquartered in Watertown, Massachusetts, United States. | Seed / May 08, 2024 | |
WeWALK
|
WeWALK, making the white cane innovative and smart, allows visually impaired people to walk more independently and safely and thanks to its three revolutionary features, it promotes their participation in social life on an equal foot with everyone.Obstacle detection: : WeWALK detects obstacles at head and chest level with its onboard ultrasonicsensor and warns its users with vibration patterns.Pairs with smart phones: : When connected with the WeWALK application via Bluetooth, GPS navigation is easy with WeWALK without the need to take out the phone.It gets better with new integrations: Every integration made possible with software updates brings new features to WeWALK. With its smart city solutions, WeWALK enables visually impaired people to access beneficial information around them such as nearby cafes and shops, while also providing them the info for closest public transport stops and arrival times. WeWALK has been developed so that it can gain new features such as nde hailing in the future with its ability to be integrated with new applications. WeWALK integrations developed so far include "Google Maps" and Alexa virtual assistant service. | Venture - Series Unknown / Feb 27, 2024 | |
Reveleum
|
Reveleum provides an innovative solution for improving the efficiency of medical record processing through automated e-faxing, standardization of medical records, and enhanced searchability. | Seed |
Co-Investors
About Elev X!
Elev X! is a venture studio program and provides funding, mentorship from industry leaders. It is a a accelerator program of NEC X.
Elev X! Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Shintaro Matsumoto
President & CEO
|
|||
Naoto Mizuguchi
CFO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shintaro Matsumoto invest in?
Shintaro Matsumoto invests primarily in Health Care, Medical and Legal Tech startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Shintaro Matsumoto?
Public channels for Shintaro Matsumoto include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Shintaro Matsumoto last invest?
The most recent investment recorded for Shintaro Matsumoto closed in May 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
